We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
ICU Medical Inc.’s (ICUI - Free Report) subsidiary, Smiths Medical, has issued a recall for certain Bivona neonatal and adult tracheostomy tubes due to a defect in the securement flange, which can lead to tear and cause severe health complications. Bivona pediatric and adult tracheostomy tubes offer airway access for up to 29 days in tracheostomy patients, with some tubes being reusable for the same patient.
The recall affects a range of products such as Bivona Aire-Cuf, TTS, Uncuffed, Mid-Range Neonatal Tracheostomy Tubes and Bivona Aire-Cuf, TTS, Cuffless FlexTend, and TTS FlexTend Adult Tracheostomy Tubes. The recall has been classified as a high-risk recall by the FDA, following reported cases of injuries and fatalities.
ICU Medical has urged immediate discontinuation and disposal of the affected products to ensure patient safety.
Likely Trend of ICUI Stock Following the News
Following the news release, shares of ICUI rose 0.8% to $177.61 at yesterday’s closing.
ICU Medical’s recall of defective tracheostomy tubes demonstrates the company’s commitment to patient safety and product quality. By proactively addressing the issue, ICU Medical reinforces its dedication to providing safe, reliable medical devices, ensuring positive sentiment around the company's focus on delivering life-saving care across healthcare settings.
Significance of ICU Medical’s Recall of Tracheostomy Tubes
Per ICU Medical, this recall is critical due to the life-threatening risks posed by the defective tracheostomy tubes, including loss of airway protection, inadequate ventilation and potential death. With 35 reported injuries and two fatalities, the recall highlights the importance of stringent manufacturing standards for life-saving medical devices. Smiths Medical's swift response, including clear disposal instructions and replacement assistance, underscores the urgency of ensuring patient safety.
Market Prospects Favoring ICUI
Per a report in Grand View Research, the global tracheostomy tubes market size is estimated to be worth $107 million in 2024. It is anticipated to reach $136.7 million by 2030 at a CAGR of 4.2%.
The robust growth is likely to be driven by the rising prevalence of chronic respiratory diseases, an aging population and technological advancements. In addition, growing awareness of tracheostomy procedures, increased demand for home care, and favorable reimbursement policies are increasing the demand for tracheostomy tubes.
ICUI’s Stock Price Performance
Shares of ICU Medical have surged 78.1% year to date compared with the industry’s 14.1% growth. The S&P 500 has risen 19.9% in the same time frame.
Image Source: Zacks Investment Research
Zacks Rank & Other Key Picks
Currently, ICU Medical carries a Zacks Rank #2 (Buy).
Some other top-ranked stocks in the broader medical space are Universal Health Services (UHS - Free Report) , ATI Physical Therapy (ATIP - Free Report) and Aveanna Healthcare (AVAH - Free Report) . While Universal Health Services sports a Zacks Rank #1 (Strong Buy), ATI Physical Therapy and Aveanna Healthcare carry a Zacks Rank #2 each at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Universal Health Services has an estimated long-term growth rate of 19%. UHS’ earnings surpassed estimates in each of the trailing four quarters, with the average being 14.58%.
Universal Health Services has gained 41.1% compared with the industry's 34.8% growth year to date.
ATI Physical Therapy's earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 7.25%.
ATIP's shares have gained 5.5% year to date compared with the industry’s 18.6% growth.
Aveanna Healthcare's earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 47.5%.
AVAH's shares have surged 104.5% year to date compared with the industry’s 15.7% growth.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
ICU Medical's Stock Rises Despite Bivona Tracheostomy Tube Recall
ICU Medical Inc.’s (ICUI - Free Report) subsidiary, Smiths Medical, has issued a recall for certain Bivona neonatal and adult tracheostomy tubes due to a defect in the securement flange, which can lead to tear and cause severe health complications. Bivona pediatric and adult tracheostomy tubes offer airway access for up to 29 days in tracheostomy patients, with some tubes being reusable for the same patient.
The recall affects a range of products such as Bivona Aire-Cuf, TTS, Uncuffed, Mid-Range Neonatal Tracheostomy Tubes and Bivona Aire-Cuf, TTS, Cuffless FlexTend, and TTS FlexTend Adult Tracheostomy Tubes. The recall has been classified as a high-risk recall by the FDA, following reported cases of injuries and fatalities.
ICU Medical has urged immediate discontinuation and disposal of the affected products to ensure patient safety.
Likely Trend of ICUI Stock Following the News
Following the news release, shares of ICUI rose 0.8% to $177.61 at yesterday’s closing.
ICU Medical’s recall of defective tracheostomy tubes demonstrates the company’s commitment to patient safety and product quality. By proactively addressing the issue, ICU Medical reinforces its dedication to providing safe, reliable medical devices, ensuring positive sentiment around the company's focus on delivering life-saving care across healthcare settings.
Significance of ICU Medical’s Recall of Tracheostomy Tubes
Per ICU Medical, this recall is critical due to the life-threatening risks posed by the defective tracheostomy tubes, including loss of airway protection, inadequate ventilation and potential death. With 35 reported injuries and two fatalities, the recall highlights the importance of stringent manufacturing standards for life-saving medical devices. Smiths Medical's swift response, including clear disposal instructions and replacement assistance, underscores the urgency of ensuring patient safety.
Market Prospects Favoring ICUI
Per a report in Grand View Research, the global tracheostomy tubes market size is estimated to be worth $107 million in 2024. It is anticipated to reach $136.7 million by 2030 at a CAGR of 4.2%.
The robust growth is likely to be driven by the rising prevalence of chronic respiratory diseases, an aging population and technological advancements. In addition, growing awareness of tracheostomy procedures, increased demand for home care, and favorable reimbursement policies are increasing the demand for tracheostomy tubes.
ICUI’s Stock Price Performance
Shares of ICU Medical have surged 78.1% year to date compared with the industry’s 14.1% growth. The S&P 500 has risen 19.9% in the same time frame.
Image Source: Zacks Investment Research
Zacks Rank & Other Key Picks
Currently, ICU Medical carries a Zacks Rank #2 (Buy).
Some other top-ranked stocks in the broader medical space are Universal Health Services (UHS - Free Report) , ATI Physical Therapy (ATIP - Free Report) and Aveanna Healthcare (AVAH - Free Report) . While Universal Health Services sports a Zacks Rank #1 (Strong Buy), ATI Physical Therapy and Aveanna Healthcare carry a Zacks Rank #2 each at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Universal Health Services has an estimated long-term growth rate of 19%. UHS’ earnings surpassed estimates in each of the trailing four quarters, with the average being 14.58%.
Universal Health Services has gained 41.1% compared with the industry's 34.8% growth year to date.
ATI Physical Therapy's earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 7.25%.
ATIP's shares have gained 5.5% year to date compared with the industry’s 18.6% growth.
Aveanna Healthcare's earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 47.5%.
AVAH's shares have surged 104.5% year to date compared with the industry’s 15.7% growth.